Serration Angioplasty Is Associated With Less Recoil in Infrapopliteal Arteries Compared With Plain Balloon Angioplasty.

arterial recoil early lumen loss infrapopliteal angioplasty serration angioplasty standard angiography

Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
07 Dec 2023
Historique:
medline: 7 12 2023
pubmed: 7 12 2023
entrez: 7 12 2023
Statut: aheadofprint

Résumé

Recoil following balloon angioplasty of tibial arteries is a known mechanism of lumen loss and widely considered to be a contributing factor in early failure or later restenosis. The Serranator balloon has been designed to provide a controlled lumen gain while minimizing vessel injury. The objective of this study was to assess the ability to define and measure postangioplasty recoil in infrapopliteal arteries and to compare recoil after serration angioplasty and plain balloon angioplasty (POBA). This multicenter, sequential comparative study included patients with lesions of infrapopliteal arteries up. Patients were enrolled sequentially and underwent alternating POBA or serration angioplasty with Serranator. The study captured angiographic imaging at pre, immediately post, and 15-minute after angioplasty. Vessel recoil, final diameter stenosis, and dissection were compared using core laboratory analysis. This study enrolled 36 patients who underwent treatment of 39 infrapopliteal lesions. There was no significant difference between Serranator (n=20) and POBA (n=19) with respect to baseline demographics and lesion characteristics. Arterial recoil (>10%) occurred in 25% of Serranator-treated lesions versus 64% in POBA-treated lesions (p=0.02. Clinically relevant recoil (>30%) was present after serration angioplasty in 10% of patients and after POBA in 53% (p=0.01). There was no significant difference in technical success (100% for both), dissection rate between Serranator (5%) and POBA (5.2%). Recoil occurs after infrapopliteal angioplasty with serration angioplasty produces substantially less arterial recoil compared with POBA. Additional studies are needed to assess whether reduced arterial recoil translates into superior long-term clinical outcomes. Prior studies have demonstrated over 90% recoil in patients after balloon angioplasty (POBA) of the infrapopliteal vessels, which significantly impacts the durability and impact of endovascular interventions in this clinical space. This study compared recoil after infrapopliteal angioplasty with serration angioplasty and POBA. Serration angioplasty produces substantially less arterial recoil compared with POBA. Additional studies are needed to assess whether reduced arterial recoil translates into superior long-term clinical outcomes.

Identifiants

pubmed: 38059463
doi: 10.1177/15266028231215284
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15266028231215284

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: PAS is a consultant for Cagent, Boston Scientific, Medtronic, Philips, Silk Road, LimFlow, Surmodics, Abbott (DSMB). RG is the Chief Technical Officer and VP Clinical Research at Cagent and a Cagent Vascular stockholder. ML is a Cagent Vascular stockholder. The rest of authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Arash Fereydooni (A)

Division of Vascular and Endovascular Surgery, Department of Surgery, Stanford University, Stanford, CA, USA.

Venita Chandra (V)

Division of Vascular and Endovascular Surgery, Department of Surgery, Stanford University, Stanford, CA, USA.

Peter A Schneider (PA)

Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA.

Robert Giasolli (R)

Cagent Vascular LLC., Wayne, PA, USA.

Michael Lichtenberg (M)

Vascular Center, Klinikum Hochsauerland, Arnsberg, Germany.

Stefan Stahlhoff (S)

Vascular Center, Klinikum Hochsauerland, Arnsberg, Germany.

Classifications MeSH